Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Germany ,Salt Lake City ,Utah ,United States ,United Kingdom ,Italy ,Toronto ,Ontario ,Canada ,France ,Spain ,Meredith Brown Tuttle ,Exchange Commission ,Linkedin ,Regulatory Affairs ,Twitter ,European Union ,European Commission ,Drug Administration ,Recursion Orphan Drug Designation ,Vice President ,Orphan Drug Designation ,Orphan Drug ,Fast Track ,Recursion Operating System ,Recursion Data ,Recursion Map ,San Francisco Bay ,Securities Litigation Reform Act ,Technology ,Science ,Health ,Biology ,Tumors ,Europe ,Business ,Pr Newswire ,